Web-delivery Treatment for Substance Abuse
CTN 0044: Web-delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
Protocol ID
10-016A
Protocol Description
The purpose of this study is to find out whether a computer-delivered treatment, called the Therapeutic Education System (TES), may be helpful as part of treatment for substance abuse problems.
Eligibility Criteria
Patients with substance abuse problems
Primary Investigator(s)
- Bruce Goldman, LCSW, CASAC
Contact Information
Last Update
May 11, 2010How did I get to this page?
Related Information
-
News Room
- Harvey Cushing Brain Tumor Institute Launches Clinical Trial to Explore New Experimental Noninvasive Device to Treat Advanced Brain Tumors
- Harvey Cushing Spine Center Expands to Lynbrook
- College Student and Former Track Star Paralyzed in January Car Crash on LIE Walks Out of Southside Hospital After Miraculous Recovery
- New Stent Graft Enables Surgeons to Treat Large Aneurysms with Minimally Invasive Technique
- Scientists Figure Out How the Immune System and Brain Communicate to Control Disease
- North Shore University Hospital's Stroke Care Program Awarded Certification from the Joint Commission
- Scientists Identify Two Distinct Parkinson's Networks
- New Treatment Option at Glen Cove Hospital to Repair Aneurysms
- Disease Scientists Discover a Pathway in the Cause of Alzheimer's
- Southside Hospital Institute of Neurosciences Opens Video-EEG Program to map Epileptic Seizures
- North Shore-LIJ Neurosurgeons Implant New Artificial Disc To Relieve Intolerable Neck and Arm Pain
- Damage to Brain Circuit Predicts Symptoms in Huntington's Disease
- Scientists Discover a Direct Route from the Brain to the Immune System
- PET Scans Show Gene Therapy Normalizes Brain Function in Parkinson's Patients
- Skull Base Surgery and New Technology Get Patient Back to Active Lifestyle
- LIJ Opens New Clinic Aimed at Preventing Stroke
- North Shore-LIJ Recruits Patients for Migraine Study
-
Clinical Trials
- Movement Disorders - Functional Correlates Study (08-191)
- Parkinson's Disease - Imaging Study (07-097)
- Parkinson's Disease - Molecular Basis for Cognitive Impairment (06-108T)
- Laparoscopic Experience and Functional Brain Activation (07-106)
- Parkinson's Disease - Genetic Study (07-058)
- Parkinson's Disease - Patient Registry (07-098)
- REM Behavior Disorder and Parkinsonism: Longitudinal PET Study (08-126)
- Neuroendocrine Tumors - Imaging Study (03-117)
- Parkinson's Disease Study - (08-270)
- Brain and Behavior in Dystonia Study (08-283)
- Cannabis - Dopamine Study - (09-002)
- MIF - Spinal Cord Injury Study (09-026)
- Psychosis - PET Study (09-037)
- Schizophrenia-like Effects of Cannibinoids (09-157)
- Quality Reporting
General Navigation
Persistent Navigation
-
Clinical Trials
- Addiction
- Aging
- Allergies
- Arthritis
- Autoimmune Disease
- Blood Disorders
- Cancer
- Children's Health
- Circulation
- Dental
- Diabetes
- Eyes
- Genetics
- Heart
- HIV
- Infectious Diseases
- Joints
- Kidney
- Lung
- Lupus
- Men's Health
- Mental Health
-
Neurosciences
- Alzheimer's Disease - Memantine Study (06.02.108T)
- Autism Spectrum Disorders - Adult Study (07.04.051)
- Brain and Behavior in Dystonia: A Multicenter Study (03.02.079G)
- Brain and Behavior in Dystonia Study (08-283)
- Brain AVM - Clinical Trial (06.02.063)
- Brain Networks in Parkinson's Disease (04-113T)
- Cannabis - Dopamine Study - (09-002)
- Clinical Correlates of Memory Impairment (03.08.160)
- Dementia - Clinical Trial (08-295)
- Dystonia - Deep Brain Stimulation Study (06-109T)
- Epilepsy
- Epilepsy - Cognitive and Sensorimotor Study (07-125)
- Epilepsy - Genetic Marker and Enzyme Study (07.08.009)
- Epilepsy - Multicenter Study (06.08.058)
- Glioblastoma - Clinical Trial (08-06-234)
- Huntington's Disease - Biomarker Study (07-018T)
- Huntington's Disease - Clinical Trial (09-012)
- Huntington's Disease - Coenzyme Q10 Study (07-124)
- Laparoscopic Experience and Functional Brain Activation (07-106)
- Memory Disorders Study (08-219)
- Metastatic Brain Tumor Study (08-10-24)
- MIF - Spinal Cord Injury Study (09-026)
- Movement Disorders - Functional Correlates Study (08-191)
- Multiple Sclerosis - Diffusion Tensor MRI Correlates of Depression (03.02.084T)
- Neuroendocrine Tumors - Imaging Study (03-117)
- Parkinson's disease - Clinical Trial (06-058)
- Parkinson's Disease - Creatine vs. Placebo Study (06.06.080T)
- Parkinson's Disease Genetics Database (07-057)
- Parkinson's Disease - Genetic Study (07-058)
- Parkinson's Disease - Imaging Study (07-097)
- Parkinson's Disease - Molecular Basis for Cognitive Impairment (06-108T)
- Parkinson's Disease - Patient Registry (07-098)
- Parkinson's Disease Study - (08-270)
- Parkinson Disease - Coenzyme Q10 Study (08-095)
- Pitch Recognition in Autistic Spectrum Disorders (04-053)
- REM Behavior Disorder and Parkinsonism: Longitudinal PET Study (08-126)
- Schizophrenia-like Effects of Cannibinoids (09-157)
- Swallowing Therapy Study (07-130)
- Web-delivery Treatment for Substance Abuse (10-016A)
- Skin
- Sleep Disorders
- Smoking
- Urinary Tract
- Weight Control
- Women's Health